Ido Kanyon

Ido Kanyon is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Fellow at The College of Physicians of Philadelphia and as Co-Founder at Halophilix, Ido has also taken on the roles of Business Development Executive and Board Member at AICC(WA). Previously, Ido held the position of Chief Executive Officer at AusCann and made significant contributions as Global Head of Specialty Pipeline Portfolio at Teva Pharmaceuticals USA, where strategic management of a $10 billion portfolio was achieved. Additional leadership roles at Teva Pharmaceuticals included directing commercial strategies in respiratory marketing and overseeing global transformations across multiple countries, driving both operational excellence and substantial cost savings. Ido's educational background includes an Executive MBA from IE Business School and a Bachelor of Science from The Hebrew University of Jerusalem.